Document is current
Any future updates will be listed below
-
Authors
Fragiotta, Serena https://orcid.org/0000-0002-6214-6270
Parravano, Mariacristina
Sacconi, Riccardo https://orcid.org/0000-0003-2891-2012
Polito, Maria Sole
Capuano, Vittorio
Costanzo, Eliana
Tombolini, Beatrice
Souied, Eric H.
Bandello, Francesco https://orcid.org/0000-0003-3238-9682
Querques, Giuseppe https://orcid.org/0000-0002-3292-9581
-
Funding
Funding for this research was provided by:
Ministero della Salute
- License Information
-
More Information
Article History
Received: 17 July 2023
Revised: 7 July 2024
Accepted: 10 July 2024
First Online: 17 July 2024
Competing interests
: The authors have no proprietary/financial interest regarding the publication of this study. M. Parravano reports personal fees from Allergan, Novartis, Bayer, Zeiss, Omikron, Alfaintes, Sifi outside the submitted work. R. Sacconi reported personal fees from: Novartis, Bayer, Zeiss outside the submitted work. V. Capuano is consultant for ZEISS (Dublin, USA). G. Querques: Alimera Sciences, Inc.: Consultant/Advisor; Allegro: Advisor; Allergan: Consultant/Advisor; Apellis : Consultant/Advisor; Baush & Lomb: Consultant; Bayer Healthcare Pharmaceuticals: Consultant/Advisor; Boehringer Ingelheim: Advisor; CenterVue: Consultant/Advisor; Heidelberg Engineering: Consultant/Advisor; Lumithera: Advisor; Nevacar: Advisor; Novartis Pharmaceuticals Corporation: Consultant/Advisor; Roche: Consultant/Advisor SIFI: Advisor/Consultant; Sooft/Fidia: Consultant; Topcon: Consultant; Thea: Consultant; Zeiss: Consultant/Advisor. E. H. Souied-consultant for Allergan, Bayer, Novartis, and Roche. F. Bandello -Consultant: Alcon, Alimera Sciences, Allergan, Farmila Théa, Bayer Schering Pharma, Bausch + Lomb, Genentech, Hoffmann-La Roche, Novagali Pharma, Novartis, Sanofi-Aventis, ThromboGenics, Zeiss. The remaining authors have nothing to disclose.
